Back to search
FDAFDA · Food and drugs·Recall number D-1255-2014

Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-0272-06

Published April 30, 2014 · Recall initiated: April 14, 2014

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.

What to do

Voluntary: Firm initiated · Telephone

Recall details

Manufacturer
Upsher Smith Laboratories, Inc.
Distributor
Nationwide
Lot
Lot #2802.042A, Exp. 10/2015
Risk classification
Class III
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card